BIM
SGYP

BlackRock Investment Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

BlackRock Investment Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.34M Sell
712,984
-4,001
-0.6% -$20.9K 0.01% 1684
2016
Q3 		$3.95M Buy
716,985
+12,490
+2% +$58.5K ﹤0.01% 1649
2016
Q2 		$2.68M Buy
704,495
+348,419
+98% +$1.18M ﹤0.01% 1885
2016
Q1 		$983K Buy
356,076
+4,454
+1% +$16.1K ﹤0.01% 2499
2015
Q4 		$1.99M Buy
351,622
+77
+0% +$469 ﹤0.01% 2086
2015
Q3 		$1.86M Sell
351,545
-4,600
-1% -$35.6K ﹤0.01% 2124
2015
Q2 		$2.96M Buy
356,145
+83,685
+31% +$406K ﹤0.01% 1919
2015
Q1 		$1.26M Buy
272,460
+426
+0.2% +$1.39K ﹤0.01% 2367
2014
Q4 		$830K Sell
272,034
-2,718
-1% -$8.04K ﹤0.01% 2669
2014
Q3 		$765K Buy
274,752
+4,945
+2% +$17.9K ﹤0.01% 2691
2014
Q2 		$1.1M Buy
269,807
+45,676
+20% +$194K ﹤0.01% 2537
2014
Q1 		$1.19M Sell
224,131
-3,628
-2% -$20.3K ﹤0.01% 2387
2013
Q4 		$1.26M Sell
227,759
-3,348
-1% -$14.4K ﹤0.01% 2335
2013
Q3 		$1.04M Buy
231,107
+17,598
+8% +$78.9K ﹤0.01% 2411
2013
Q2 		$910K Buy
+213,509
New +$1.07M ﹤0.01% 2435

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock Investment Management's SGYP Position: Q4 2016 in Review

BlackRock Investment Management reduced its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 0.56% in Q4 2016, selling an estimated $20.9K and leaving 712,984 shares worth $4.34M. The position accounts for 0.01% of the portfolio, ranked #1684.

BlackRock Investment Management first reported a position in SGYP in Q2 2013 and has held it in 15 quarters since. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • BlackRock Investment Management held 712,984 shares of Synergy Pharmaceuticals, Inc Common Stock worth $4.34M as of Q4 2016.
  • BlackRock Investment Management sold 4,001 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $20.9K.
  • Synergy Pharmaceuticals, Inc Common Stock made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1684 holding.
  • BlackRock Investment Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and has held it in 15 quarters since.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.